Molecular toxicological alterations in the mouse hearts induced by sub‐chronic thiazolidinedione drugs administration
- 9 May 2021
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 36 (1) , 143-149
Abstract
Thiazolidinediones are well known anti‐diabetic drugs. However, they are not widely used due to their cardiotoxic effects. Therefore, in this study we aimed to determine the molecular toxicological alterations induced in the mouse hearts after thiazolidinedione administration. Balb/c mice received doses clinically equivalent to those given to humans of the most commonly used thiazolidinediones, pioglitazone, and rosiglitazone for 30 days. After that, RNA samples were isolated from the hearts. The mRNA expression of cytochrome (cyp) p450 genes that synthesize the cardiotoxic 20‐hydroxyecostarionic acid (20‐HETE) in addition to 92 cardio‐toxicity biomarker genes were analyzed using quantitative polymerase chain reaction array technique. The analysis demonstrated that thiazolidinediones caused a significant upregulation (p < 0.5) of the mRNA expression of cyp1a1,cyp4a12,itpr1,ccl7,ccr1, and b2m genes. In addition, thiazolidinediones caused a significant (p < 0.05) downregulation of the mRNA expression of adra2a,bsn,col15a1,fosl1,Il6,bpifa1,plau, and reg3b genes. The most affected gene was was itpr1 gene, which was upregulated by pioglitazone and rosiglitazone by 7‐ and 3.5‐fold, respectively. In addition, pioglitazone caused significant upregulation of (p < 0.05) hamp,ppbp,psma2,sik1,timp1, and ucp1 genes, which were not affected significantly (p > 0.05) by rosiglitazone administration. In conclusion, this study showed that thiazolidinediones induces toxicological molecular alterations in the mouse hearts, such as the induction of cyp450s that synthesize 20‐HETE, chemokine activation, inflammatory responses, blood clotting, and oxidative stress. These findings may help us understand the mechanism of cardiotoxicity involved in thiazolidinedione administration.Keywords
This publication has 35 references indexed in Scilit:
- Change Trends of Organ Weight Background Data in Sprague Dawley Rats at Different AgesJournal of Toxicologic Pathology, 2013
- Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?Movement Disorders, 2011
- Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular eventsProceedings of the National Academy of Sciences, 2010
- Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in ratsToxicology and Applied Pharmacology, 2010
- Relationship between thiazolidinedione use and cardiovascular outcomes and all‐cause mortality among patients with diabetes: a time‐updated propensity analysisPharmacoepidemiology and Drug Safety, 2009
- Do thiazolidinediones increase the risk of congestive heart failure and cardiovascular death?Nature Clinical Practice Endocrinology & Metabolism, 2008
- Review: thiazolidinediones increase risk of heart failure in type 2 diabetesBMJ Evidence-Based Medicine, 2008
- Mitochondrial Uncoupling Protein 1 Expressed in the Heart of Transgenic Mice Protects Against Ischemic-Reperfusion DamageCirculation, 2004
- Cardiac Hypertrophy Is Associated With Decreased eNOS Expression in Angiotensin AT 2 Receptor–Deficient MiceHypertension, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001